These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30398032)

  • 21. Liver fibrosis progression in hepatitis C virus infection after seroconversion.
    Butt AA; Yan P; Lo Re V; Rimland D; Goetz MB; Leaf D; Freiberg MS; Klein MB; Justice AC; Sherman KE;
    JAMA Intern Med; 2015 Feb; 175(2):178-85. PubMed ID: 25485735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cannabis Use and Reduced Risk of Insulin Resistance in HIV-HCV Infected Patients: A Longitudinal Analysis (ANRS CO13 HEPAVIH).
    Carrieri MP; Serfaty L; Vilotitch A; Winnock M; Poizot-Martin I; Loko MA; Lions C; Lascoux-Combe C; Roux P; Salmon-Ceron D; Spire B; Dabis F;
    Clin Infect Dis; 2015 Jul; 61(1):40-8. PubMed ID: 25778750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Data mining of routine laboratory tests can predict liver disease progression in Egyptian diabetic patients with hepatitis C virus (G4) infection: a cohort study of 71 806 patients.
    Saad Y; Awad A; Alakel W; Doss W; Awad T; Mabrouk M
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):201-206. PubMed ID: 29099423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between serum vitamin D and severity of liver fibrosis in chronic hepatitis C patients: a systematic meta-analysis.
    Luo YQ; Wu XX; Ling ZX; Cheng YW; Yuan L; Xiang C
    J Zhejiang Univ Sci B; 2014 Oct; 15(10):900-6. PubMed ID: 25294379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
    Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
    Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modest alcohol consumption and risk of advanced liver fibrosis in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Wijarnpreecha K; Aby ES; Panjawatanan P; Lapumnuaypol K; Cheungpasitporn W; Lukens FJ; Harnois DM; Ungprasert P
    Ann Gastroenterol; 2021; 34(4):568-574. PubMed ID: 34276197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of hepatitis C sustained viral response on cardiovascular diseases: a meta-analysis.
    Lapumnuaypol K; Thongprayoon C; Wijarnpreecha K; Cheungpasitporn W
    Hosp Pract (1995); 2019 Aug; 47(3):105-110. PubMed ID: 31018721
    [No Abstract]   [Full Text] [Related]  

  • 30. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
    Halangk J; Sarrazin C; Neumann K; Puhl G; Mueller T; Teuber G; Klinker H; Hinrichsen H; Buggisch P; Landt O; Weich V; Bergk A; Wiedenmann B; Neuhaus P; Berg T; Witt H
    J Hepatol; 2008 Sep; 49(3):339-45. PubMed ID: 18644651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective evaluation of liver fibrosis in chronic viral hepatitis C infection using the Sabadell NIHCED (Non-Invasive Hepatitis-C-Related Cirrhosis Early Detection) index.
    Bejarano G; Vergara M; Dalmau B; Puig J; Bella MR; Suárez D; Calvet X
    Rev Esp Enferm Dig; 2009 May; 101(5):325-35. PubMed ID: 19527078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence and factors associated with significant liver fibrosis assessed by transient elastometry in HIV/hepatitis C virus-coinfected patients.
    Pineda JA; González J; Ortega E; Tural C; Macías J; Griffa L; Burgos A;
    J Viral Hepat; 2010 Oct; 17(10):714-9. PubMed ID: 20002560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stage of liver fibrosis in patients with congenital bleeding disorders and infected with hepatitis C virus.
    Kucharska M; Zaleska-Dorobisz U; Szymczak A; Inglot M; Rymer W; Zalewska M; Małyszczak K; Kuliszkiewicz-Janus M; Inglot M
    Pol Arch Intern Med; 2017 Jun; 127(6):412-417. PubMed ID: 28530647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C Cirrhosis.
    Yang JD; Mohamed HA; Cvinar JL; Gores GJ; Roberts LR; Kim WR
    Am J Gastroenterol; 2016 Nov; 111(11):1573-1580. PubMed ID: 27527741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APRI test and hyaluronic acid as non-invasive diagnostic tools for post HCV liver fibrosis: Systematic review and meta-analysis.
    El Serafy MA; Kassem AM; Omar H; Mahfouz MS; El Said El Raziky M
    Arab J Gastroenterol; 2017 Jun; 18(2):51-57. PubMed ID: 28579340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C virus infection and risk of gallstones: A meta-analysis.
    Wijarnpreecha K; Thongprayoon C; Panjawatanan P; Lekuthai N; Ungprasert P
    J Evid Based Med; 2017 Nov; 10(4):263-270. PubMed ID: 29193901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nitazoxanide for chronic hepatitis C.
    Nikolova K; Gluud C; Grevstad B; Jakobsen JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of the treatment of chronic hepatitis C virus infection in cirrhosis.
    Vezali E; Aghemo A; Colombo M
    Clin Ther; 2010 Dec; 32(13):2117-38. PubMed ID: 21316532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
    Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.